[Federal Register: January 9, 2003 (Volume 68, Number 6)] [Notices] [Page 1178] From the Federal Register Online via GPO Access [wais.access.gpo.gov] [DOCID:fr09ja03-24] ======================================================================= ----------------------------------------------------------------------- DEPARTMENT OF DEFENSE Department of the Army Availability for Non-Exclusive, Exclusive, or Partially Exclusive Licensing of U.S. Patent Application Concerning Transformed Bacteria Producing CS6 Antigens as Vaccines AGENCY: Department of the Army, (DoD). ACTION: Notice. ----------------------------------------------------------------------- SUMMARY: In accordance with 37 CFR 404.6 and 404.7, announcement is made of the availability for licensing of U.S. Patent Application No. 09/479,877 entitled ``Transformed Bacteria Producing CS6 Antigens as Vaccines,'' file January 10, 2000. The United States Government, as represented by the Secretary of the Army, has rights in this invention. ADDRESSES: Commander, U.S. Army Medical Research and Materiel Command, ATTN: Command Judge Advocate, MCMR-JA, 504 Scott Street, Fort Detrick, Frederick, MD 21702-5012. FOR FURTHER INFORMATION CONTACT: For patent issues, Ms. Elizabeth Arwine, Patent Attorney, (301) 619-7808. For licensing issues, Dr. Paul Mele, Office of Research & Technology Assessment, (301) 619-6664, both at telefax (301) 619-5034. SUPPLEMENTARY INFORMATION: This invention is related to a CS6 antigen for use in vaccines to protect from pathological effects of enterotoxigenic E. coli. Luz D. Ortiz, Army Federal Register Liaison Officer. [FR Doc. 03-435 Filed 1-8-03; 8:45 am] BILLING CODE 3710-08-M